These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 19321255

  • 1. Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF.
    Zou JN, Wang SZ, Yang JS, Luo XG, Xie JH, Xi T.
    Cancer Lett; 2009 Jul 18; 280(1):78-85. PubMed ID: 19321255
    [Abstract] [Full Text] [Related]

  • 2. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
    Liu C, Fang X, Ge Z, Jalink M, Kyo S, Björkholm M, Gruber A, Sjöberg J, Xu D.
    Cancer Res; 2007 Mar 15; 67(6):2626-31. PubMed ID: 17363582
    [Abstract] [Full Text] [Related]

  • 3. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
    Liang H, O'Reilly S, Liu Y, Abounader R, Laterra J, Maher VM, McCormick JJ.
    Int J Oncol; 2004 May 15; 24(5):1057-67. PubMed ID: 15067326
    [Abstract] [Full Text] [Related]

  • 4. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1.
    Jiang Y, Xu W, Lu J, He F, Yang X.
    Biochem Biophys Res Commun; 2001 Sep 07; 286(5):1123-30. PubMed ID: 11527416
    [Abstract] [Full Text] [Related]

  • 5. In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.
    Salvi A, Arici B, Portolani N, Giulini SM, De Petro G, Barlati S.
    Int J Oncol; 2007 Aug 07; 31(2):451-60. PubMed ID: 17611703
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
    Xie B, Xing R, Chen P, Gou Y, Li S, Xiao J, Dong J.
    J Surg Res; 2010 Aug 07; 162(2):231-8. PubMed ID: 19765730
    [Abstract] [Full Text] [Related]

  • 7. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells.
    Davies G, Watkins G, Mason MD, Jiang WG.
    Prostate; 2004 Sep 01; 60(4):317-24. PubMed ID: 15264243
    [Abstract] [Full Text] [Related]

  • 8. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K, Hashimoto T, Kitamura N, Tanaka T.
    Mol Cancer Res; 2009 Jul 01; 7(7):1179-88. PubMed ID: 19567783
    [Abstract] [Full Text] [Related]

  • 9. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
    Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, Zheng X.
    Cancer Lett; 2009 Mar 08; 275(1):44-53. PubMed ID: 19006648
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of the met receptor in mesothelioma.
    Mukohara T, Civiello G, Davis IJ, Taffaro ML, Christensen J, Fisher DE, Johnson BE, Jänne PA.
    Clin Cancer Res; 2005 Nov 15; 11(22):8122-30. PubMed ID: 16299245
    [Abstract] [Full Text] [Related]

  • 11. [Suppression of SMYD3 expression in HepG2 cell by shRNA interference].
    Xu JY, Chen LB, Xu JY, Yang Z, Wei HY, Xu RH.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Feb 15; 14(2):105-8. PubMed ID: 16494778
    [Abstract] [Full Text] [Related]

  • 12. Regulation of c-met expression by transcription repressor Daxx.
    Morozov VM, Massoll NA, Vladimirova OV, Maul GG, Ishov AM.
    Oncogene; 2008 Apr 03; 27(15):2177-86. PubMed ID: 17952115
    [Abstract] [Full Text] [Related]

  • 13. Hepatocyte growth factor/c-Met signaling promotes the progression of experimental human neuroblastomas.
    Hecht M, Papoutsi M, Tran HD, Wilting J, Schweigerer L.
    Cancer Res; 2004 Sep 01; 64(17):6109-18. PubMed ID: 15342394
    [Abstract] [Full Text] [Related]

  • 14. Novobiocin decreases SMYD3 expression and inhibits the migration of MDA-MB-231 human breast cancer cells.
    Luo XG, Zou JN, Wang SZ, Zhang TC, Xi T.
    IUBMB Life; 2010 Mar 01; 62(3):194-9. PubMed ID: 20039369
    [Abstract] [Full Text] [Related]

  • 15. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
    Matsushita A, Götze T, Korc M.
    Cancer Res; 2007 Nov 01; 67(21):10309-16. PubMed ID: 17974973
    [Abstract] [Full Text] [Related]

  • 16. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
    Xu JY, Chen LB, Xu JY, Yang Z, Xu RH, Wei HY.
    Zhonghua Wai Ke Za Zhi; 2006 Apr 01; 44(7):481-4. PubMed ID: 16772086
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis.
    Lee CC, Putnam AJ, Miranti CK, Gustafson M, Wang LM, Vande Woude GF, Gao CF.
    Oncogene; 2004 Jul 01; 23(30):5193-202. PubMed ID: 15122328
    [Abstract] [Full Text] [Related]

  • 18. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
    Watanabe T, Tsuda M, Makino Y, Ichihara S, Sawa H, Minami A, Mochizuki N, Nagashima K, Tanaka S.
    Mol Cancer Res; 2006 Jul 01; 4(7):499-510. PubMed ID: 16849525
    [Abstract] [Full Text] [Related]

  • 19. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met.
    Onimaru Y, Tsukasaki K, Murata K, Imaizumi Y, Choi YL, Hasegawa H, Sugahara K, Yamada Y, Hayashi T, Nakashima M, Taguchi T, Mano H, Kamihira S, Tomonaga M.
    Int J Oncol; 2008 Oct 01; 33(4):697-703. PubMed ID: 18813782
    [Abstract] [Full Text] [Related]

  • 20. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
    Tam EM, Runyon ST, Santell L, Quan C, Yao X, Kirchhofer D, Skelton NJ, Lazarus RA.
    J Mol Biol; 2009 Jan 09; 385(1):79-90. PubMed ID: 18973760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.